Sarcoidosis is a multisystem granulomatous disease of unknown origin. No si
ngle biological marker allows definitive diagnosis of sarcoidosis or may ac
curately predict the disease prognosis. However, some biological markers ar
e helpful tools as diagnostic aids and disease activity markers. At the blo
od level, lymphopenia with CD4 depletion, elevated levels of serum angioten
sin converting enzyme, lyzozyme, beta 2 microglobulin and disturbed calcium
metabolism resulting in hypercalcemia and hypercalciuria can help guide di
agnosis. Lymphocytic alveolitis with a high CD4/CD8 ratio in bronchoalveola
r lavage fluid is highly suggestive of the disease. A wide range of new bio
logical markers are proposed but their pronostic significance is still cont
roversial. In clinical practice, biological markers may help in monitoring
treated patients with sarcoidisis.